1. 1) Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J. Am. Coll. Cardiol., 47, 921–929 (2006).
2. 2) Pereira CA, Carneiro FS, Matsumoto T, Tostes RC. Bonus effects of antidiabetic drugs: possible beneficial effects on endothelial dysfunction, vascular inflammation and atherosclerosis. Basic Clin. Pharmacol. Toxicol., 123, 523–538 (2018).
3. 3) Zhou R, Dang X, Sprague RS, Mustafa SJ, Zhou Z. Alteration of purinergic signaling in diabetes: focus on vascular function. J. Mol. Cell. Cardiol., 140, 1–9 (2020).
4. 4) Burnstock G. Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem. Int., 17, 357–368 (1990).
5. 5) Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev., 58, 58–86 (2006).